Clinical Trial Update: Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. [NA]

View source ↗

Summary

A clinical trial at Sohag University Hospitals evaluating a combination therapy of glucose-insulin-potassium infusion, intravenous hydrocortisone, and oral seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aluminum Phosphide Poisoning

Drugs mentioned

• Glucose-Insulin-Potassium Infusion (GIK) (glucose-insulin-potassium infusion)
• HYDROCORTISONE (HYDROCORTISONE)
• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Sohag University | Conditions: Acute Aluminum Phosphide Poisoned Cases | NA | Status: NOT_YET_RECRUITING